PL EN


2012 | 2 | 280-285
Article title

Profilaktyka zakażeń wirusami pierwotnie hepatotropowymi przy wyjazdach do strefy tropikalnej

Content
Title variants
Languages of publication
PL
Abstracts
Contributors
References
  • Khuroo MS. Viral hepatitis in international travellers: risks and prevention. Int J Antimicrob Agents 2003; 21(2):143−152.
  • Dagan R. Szczepienia. JAMA 2005; 294: 202–210 (Oprac. Med Prakt Pediatria Supl. 2/2007: 25–26).
  • Steffen R. Hepatitis A and B: risks compared with other vaccine-preventable diseases and immunization recommendations.Vaccine 1993; 11, 518–520.
  • Steffen R. Hepatitis A in travelers: the European experience. J Infect Dis 1995; 171(Suppl. 1): 24−28.
  • Szczepienia ochronne w Polsce w 2005 roku. Warszawa: Państwowy Zakład Higieny; 2006.
  • Hollinger FB, Ticehurst JR. Hepatitis A virus. In. Fields virology. 3 ed. Philadelphia: Lippincott-Raven; 1996: 735–782.
  • Program Szczepień Ochronnych na rok 2010.
  • Lee SD, Chan CY, Yu MI, et al. Single dose-inactivated hepatitis A vaccination schedule for susceptible youngsters. Am J Gastroenterol 1996; 91(7): 1360–1362.
  • Andre F, Van Damme P, Safary A, Banatvala J. Miscellaneous. Inactivated hepatitis A vaccine: immunogenicity, efficacy,safety and review of official recommendations for use. Expert Rev Vaccines 2002; 1(1): 9−23.
  • Clemens R, Safary A, Hepburn A, et al. Clinical experience with an inactivated hepatitis A vaccine. J Infect Dis 1995; 171(Suppl. 1): 44–49.
  • Connor BA, VanHerck K, Van Damme P. Rapid protection and vaccination against hepatitis A for travelers. BioDrugs 2003; 17(Suppl. 1): 19−21.
  • Victor JC, Monto AS, Surdina TY, et al. Hepatitis A vaccine versus immune globulin for postexposure prophylaxis. NEJM 2007; 357: 1685–1694 (Oprac. pol. Med. Prakt. Pediatria, Supl. 2/2007): 42–44
  • CDC. Update: prevention of hepatitis A after exposure to hepatitis A virus and in international travelers. Updated recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR CDC Surveill Summ 2007; 56(41): 1080–1084.
  • Lok ASF, McMahon B. AASLD practice guidelines chronic hepatitis B: Update 2009. Hepatology 2009; 50(3): 1−36.
  • CDC. Recommended adult immunization schedule – United States, 2011. MMWR CDC Surveill Summ 2011, 60(4):1–4.
  • Van Damme P, Banatvala J, Fay O, et al. Hepatitis A booster vaccination: is there a need? Lancet 2003; 362: 1065––1071
  • Van Damme P, Van Herck K. A review of the long-term protection after hepatitis A and B vaccination. Travel Med Infect Dis 2007 Mar; 5(2): 79–84.
  • Landry P, Tremblay S, Darioli R, et al. Inactivated hepatitis A vaccine booster given ≥ 24 months after the primary dose.Vaccine 2000; 19: 399−402.
  • European Consensus Group on Hepatitis Immunity. Lancet 2000; 355: 561−565.
  • Juszczyk J, Flisiak R, Halota W, et al. Szczepienia przeciw wirusowemu zapaleniu wątroby typu A i B. Zakażenia 2011;6: 154−157..
Document Type
Publication order reference
Identifiers
YADDA identifier
bwmeta1.element.desklight-f32a3f0c-a714-4fdb-bf13-b01c413c8a4c
JavaScript is turned off in your web browser. Turn it on to take full advantage of this site, then refresh the page.